CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. SION
2. SPY
3. NVDA
4. CSQR
5. B
6. SLN
7. STDN
8. MNDY
9. TTWO
10. INTC

Go back to CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042
(NASDAQ: CRVO) Delayed: 2.87 --0 (-0%)
Previous Close $2.87    52 Week High $ 
Open $2.87    52 Week Low $ 
Day High $2.88    P/E N/A 
Day Low $2.66    EPS $ 
Volume 306,931